D-1300-2014 Class II Terminated

Recalled by Wockhardt Usa Inc. — Parsippany, NJ

FDA drug recall D-1300-2014 was initiated by Wockhardt Usa Inc. on Apr 1, 2014 and is designated Class II. Reason for recall: Failed Dissolution Specifications: failure of dissolution test observed at nine month time point. The recall status is terminated (terminated May 12, 2015). Affected quantity: 109,744 bottles.

Recall details

Product Type
Drugs
Report Date
May 14, 2014
Initiation Date
Apr 1, 2014
Termination Date
May 12, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
109,744 bottles

Product description

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.

Reason for recall

Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.

Distribution pattern

Nationwide

Code information

Lot #: LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1300-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1300-2014. Report a data issue: hello@regdatalab.com.